Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CD-NP in Heart Failure Patients with LVAD
NCT03091998Phase 1Withdrawn
- Sponsor
- Mayo Clinic
- Start
- Sep 2017
- Primary completion
- May 2019
- Modality
- Peptides, Recombinant Proteins and Enzymes
01
Overview
Phase 1, randomised, double-blind trial in heart failure (HF) comparing Study Drug (CD-NP) with Placebo (saline) (2 arms). Primary endpoint: Hypotension at 2 weeks. Planned start Sep 2017; status: withdrawn.
02
Drugs
cenderitide
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on NCT03091998.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03091998.